VTGN

NASDAQStock

VistaGen Therapeutics, Inc.

$0.61-0.02 (-3.83%)

52-Week Range

$0.51

$4.90

Key Stats

Market Cap

19.9M

P/E Ratio

—

Dividend Yield

—

Beta

0.33

Volume

439.5K

Avg Volume

583.8K

Performance

+15.74%

-85.63%

-80.59%

YTD

-7.10%

-76.64%

-86.22%

-99.07%

Price Chart

ETF Exposure

VTGN is held by 10 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
PSIL	AdvisorShares Psychedelics ETF	0.79%	277,110	$164K	$20.4M	1.84%
IWC	iShares Micro-Cap ETF	0.00%	78,438	$47K	$1.27B	0.60%
DCOR	Dimensional - US Core Equity 1 ETF	0.00%	5,491	$3K	$2.68B	0.14%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	57	$43	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	2,038	$2K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	9	$7	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	1,160,455	$648K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	6,103	$5K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	526	$397	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	413,745	$231K	$84.10B	0.05%

About VTGN ETF Exposure

VistaGen Therapeutics, Inc. (VTGN) is held by 10 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 19.9M, VTGN is a widely held institutional stock. The stock currently trades at $0.61. Investors can gain exposure to VTGN through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold VTGN, sorted by portfolio weight.